-+ 0.00%
-+ 0.00%
-+ 0.00%

Wedbush Reiterates Outperform on Solid Biosciences, Maintains $16 Price Target

Benzinga·05/18/2026 12:34:38
Listen to the news
Wedbush analyst Laura Chico reiterates Solid Biosciences (NASDAQ:SLDB) with a Outperform and maintains $16 price target.